Ketogenic Dietary Therapies in Neurological Disorders
Deadline for manuscript submissions: closed (20 September 2021) | Viewed by 45333
Interests: ketogenic dietary treatments; gut microbiota; obesity and eating disorders; assessment of nutritional status; body composition and energy expenditure
Special Issues, Collections and Topics in MDPI journals
Ketogenic dietary therapies (KDT) are established, effective nonpharmacologic treatments for intractable childhood epilepsy and some neurometabolic disorders. Today there are several ketogenic dietary therapies (KDTs) used in neurology: the classic ketogenic diet, the medium-chain triglyceride diet (MCT), the modified Atkins diet (MAD), and the low glycemic index treatment (LGIT). In a few studies a very low calorie ketogenic diet (VLCKD) has also been used. These dietary protocols differ greatly in their ketogenic potential and blood levels of ketosis. The mechanisms by which KDTs exert their antiseizure effects are likely multiple, may be different for various epilepsy conditions. There is a growing interest in using KDTs for several conditions other than epilepsy. KDTs may be efficacious in improving brain cancer survival and slowing progression. Ketogenesis may be a useful therapeutic strategy for migraines. In Alzheimer’s disease medium-chain triglyceride supplements have been shown to improve short-term cognitive performance in clinical studies. In autism, metabolic or mitochondrial dysfunction has been implicated as an underlying pathophysiology, with KDTs being used to target this dysfunction. Preclinical data suggest that KDTs may modulate immunity, reduce disease severity and promote remyelination in the mouse model of Multiple Sclerosis. Although KDTs use in several neurological conditions is promising, understanding mechanisms underlying its efficacy and larger studies are needed for these diverse disorders. While ketosis remain a feasible indicator of dietary compliance, its relationship with clinical efficacy has not been completely clarified. This issue is aimed at collecting studies on a) emerging applications of KDTs in neurology and b) definition of the best dietary protocol and level of ketosis to implement in the different clinical conditions.
Prof. Dr. Anna Tagliabue
Dr. Cinzia Ferraris
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- ketogenic dietary therapies
- ketogenic potential, ketosis
- classic ketogenic diet
- modified Atkins diet
- low-glycemic diet
- medium chain triglycerides
- Alzheimer’s disease
- brain cancer
- multiple sclerosis, migraine
- gut microbiota